By Professor William Rawlinson

Conference Abstracts

Figueroa-Crisostomo C; Akil A; Ho A; Hardikar A; Farr R; Rawlinson W; Craig M, 2014, 'Differentially expressed circulating and cell associated microRNAs in the investigation of the role of viral infection in type 1 diabetes', in Qatar Foundation Annual Research Conference Proceedings, Hamad bin Khalifa University Press (HBKU Press), Vol. 2014, presented at Qatar Foundation Annual Research Conference, http://dx.doi.org/10.5339/qfarc.2014.HBPP0482

Muscatello DJ; Amin J; MacIntyre CR; Newall AT; Rawlinson WD; Sintchenko V; Gilmour R; Thackway S, 2014, 'Under-ascertainment of Illness due to Influenza in Administrative Databases, a Population-based Record Linkage Study', in Online J Public Health Inform, University of Illinois at Chicago Library, Vol. 6, pp. e169, http://dx.doi.org/10.5210/ojphi.v6i1.5189

Micallef JM; Jauncey M; Amin J; Rawlinson W; Gilmour S; van Beek I; Kaldor JM; White PA; Dore GJ, 2003, 'Hepatitis C virus reinfection within a cohort of injecting drug users.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, Vol. 38, pp. 266A - 266A, presented at 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, MASSACHUSETTS, BOSTON, 24 October 2003 - 28 October 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185816700230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G, 2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, Vol. 32, pp. 279A - 279A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Working Papers

Capraro A; Wong S; Adhikari A; Allan K; Patel H; Zhong L; Raftery M; Jaffe A; Yeang M; Aggarwal A; Wu L; Pandzic E; Whan R; Turville S; Vittorio O; Bull R; Kaakoush N; Rawlinson W; Tedla N; Vafaee F; Waters S, 2021, Ageing impairs the airway epithelium defence response to SARS-CoV-2, http://dx.doi.org10.1101/2021.04.05.437453

Preprints

Aggarwal A; Ognenovska S; Ison T; Fichter C; Milogiannakis V; Afzal M; Stella AO; Waters S; Esneau C; Bartlett N; Pöhlmann S; Hoffmann M; Burrell L; Patel S; Ellis S; Wehrhahn M; Martinez E; Ginn A; Churchill M; Angelovich T; Rawlinson W; Yeang M; Kok J; Sintchenkov V; Parry R; Sng J; Neely G; Moreno C; Loo L; Kelleher A; Brilot F; Khromykh A; Turville S, 2025, Replication of SARS-CoV-2 Omicron lineages is defined by TMPRSS2 use in environments where ACE2 is complexed with solute carriers SLC6A19 and SLC6A20, http://dx.doi.org/10.1101/2025.07.07.663433

Koirala A; McRae J; Britton PN; Downes M; Prasad SA; Nicholson S; Winkler NE; O’Sullivan MVN; Gondalwala F; Castellano C; Carey E; Hendry A; Crawford N; Wadia U; Richmond P; Marshall HS; Clark JE; Francis JR; Carr J; Bartlett A; McMullan B; Skowno J; Hannah D; Davidson A; von Ungern-Sternberg BS; Lee-Archer P; Burgoyne LL; Waugh EB; Carlin JB; Naing Z; Kerly N; McMinn A; Hunter G; Heath C; D’Angelo N; Finucane C; Francis LA; Dougherty S; Rawlinson W; Karapanagiotidis T; Cain N; Brizuela R; Blyth CC; Wood N; Macartney K, 2024, The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study, http://dx.doi.org/10.1101/2024.03.03.24303672

Zufan S; Lau K; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson W; Ballard S; Stinear T; Howden B; Jennison A; Seemann T, 2023, Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance, http://dx.doi.org/10.1101/2023.02.01.526694

Foster CSP; Walker G; Jean T; Wong M; Brassil L; Isaacs S; Lyu Y; Turville S; Kelleher A; Rawlinson W, 2023, Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution, http://dx.doi.org/10.1101/2023.11.02.565396

Aggarwal A; Fichter C; Milogiannakis V; Ison T; Ruiz Silva M; Esneau C; Bartlett N; Burrell L; Patel S; Churchill M; Angelovich T; Walker G; Rawlinson W; Yeang M; Kok J; Sintchenkov V; Chandra D; Kindinger A; Akerman A; Parry R; Sng J; Neely G; Moreno C; Loo L; Kelleher A; Brilot F; Khromykh A; Turville S, 2023, TMPRSS2 activation of Omicron lineage Spike glycoprotein is regulated by Collectrin-like domain of ACE2, http://dx.doi.org/10.1101/2023.09.22.558930

Schütz M; Müller R; Socher E; Wangen C; Full F; Wyler E; Wong D; Scherer M; Stamminger T; Chou S; Rawlinson WD; Hamilton ST; Sticht H; Marschall M, 2022, Highly conserved interaction profiles between clinically relevant mutants of the cytomegalovirus CDK-like kinase pUL97 and human cyclins: functional significance of cyclin H, http://dx.doi.org/10.21203/rs.3.rs-1676959/v1

Rouet R; Henry J; Johansen M; Sobti M; Balachandran H; Langley D; Walker G; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett D; Brown S; Martinello M; Hudson B; Gilroy N; Post J; Kelleher A; Jäck H-M; Goodnow C; Turville S; Rawlinson W; Bull R; Stewart A; Hansbro P; Christ D, 2022, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, http://dx.doi.org/10.1101/2022.10.19.512954

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fitcher C; Lopez J; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett N; Darley D; Matthews G; Stark D; Rawlinson W; Murrell B; Brilot F; Cunningham A; Kelleher A; Aggarwal A; Turville S, 2022, Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level, http://dx.doi.org/10.1101/2022.12.06.22283000

Foster CSP; Bull R; Tedla N; Santiago F; Agapiou D; Adhikari A; Walker G; Shrestha LB; van Hal S; Kim KW; Rawlinson W, 2022, Persistence of a SARS-CoV-2 variant with a frameshifting deletion for the duration of a major outbreak, http://dx.doi.org/10.1101/2022.09.06.22279658

Aggarwal A; Stella A; Akerman A; Walker G; Milogiannakis V; McAllery S; Esneau C; Silva MR; Lu Y; Forster C; Hal SV; Mathivanan V; Fitcher C; Hoppe AC; Munier ML; Darley D; Matthews G; Starck D; Robosa R; Bartlett N; Rawlinson W; Kelleher A; Turville S, 2022, Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants, http://dx.doi.org/10.21203/rs.3.rs-1210846/v1

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Yeang M; Jean T; Foster C; Hoppe AC; Munier ML; Darley D; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern, http://dx.doi.org/10.2139/ssrn.4157473

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Coppola G; Yeang M; Jean T; Foster C; Hoppe AC; Ling Munier M; Darley D; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.1101/2022.07.07.22277128

Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.21203/rs.3.rs-1207364/v1

Foster CSP; Stelzer-Braid S; Deveson I; Bull R; Yeang M; Phan-Au J; Silva MR; van Hal S; Rockett R; Sintchenko V; Kim KW; Rawlinson W, 2021, Assessment of inter-laboratory differences in SARS-CoV-2 consensus genome assemblies between public health laboratories in Australia, http://dx.doi.org/10.1101/2021.08.19.21262296

Tennant E; Figtree M; Tallon J; Bull R; Yeang M; Deveson I; Ferguson J; Adikari T; Holmes E; Hal SV; Hammond J; Stevanovski I; Mitsakos K; Hilditch-Roberts D; Rawlinson W; Hudson B, 2021, Epidemiological and Genomic analysis of a Sydney Hospital COVID-19 Outbreak, http://dx.doi.org/10.1101/2021.02.17.21251943

Adhikari A; Abayasingam A; Rodrigo C; Agapiou D; Pandzic E; Brasher N; Madushan Fernando BS; Keoshkerian E; Li H; Kim HN; Lord M; Popovic G; Rawlinson W; Mina M; Post J; Hudson B; Gilroy N; Bartlett A; Ahlenstiel G; Grubor-Bauk B; Dwyer D; Konecny P; Lloyd A; Martinello M; Bull R; Tedla N, 2021, Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection, http://dx.doi.org/10.1101/2021.12.21.473774

Foster CSP; Rawlinson W, 2021, Rapid spread of a SARS-CoV-2 Delta variant with a frameshift deletion in ORF7a, http://dx.doi.org/10.1101/2021.08.18.21262089

Walker G; Davis R; Naing Z; McEntee B; Lu Y; Denadija T; Rawlinson W, 2021, Serological detection of SARS-CoV-2 IgG using commercially available immunoassays on dried blood spots collected from patients, http://dx.doi.org/10.1101/2021.08.11.21261877

Roth-Schulze A; Penno M; Ngui K; Oakey H; Bandala-Sanchez E; Smith A; Allnutt T; Thomson R; Vuillermin P; Craig M; Rawlinson W; Davis E; Harris M; Soldatos G; Colman P; Wentworth J; Haynes A; Morahan G; Bediaga N; Smyth G; Papenfuss A; Couper J; Harrison L, 2021, Type 1 Diabetes in Pregnancy Is Associated With Distinct Changes in the Composition and Function of the Gut Microbiome, http://dx.doi.org/10.21203/rs.3.rs-376289/v1

Isaacs S; Foskett D; Maxwell A; Ward E; Faulkner C; Luo J; Rawlinson W; Craig M; Kim KW, 2021, Viruses and Type 1 Diabetes: From Enteroviruses to the Virome, http://dx.doi.org/10.20944/preprints202106.0574.v1

Yeung VA; Thapa K; Rawlinson W; Georgiou A; Post J; Overton K, 2020, Differences in Antibiotic and Antiviral Use in People With Confirmed Influenza: a Retrospective Comparison of Rapid Influenza PCR and Multiplex Respiratory Virus PCR Tests., http://dx.doi.org/10.21203/rs.3.rs-109807/v1

Lau KA; da Silva AG; Theis T; Gray J; Ballard SA; Rawlinson WD, 2020, Proficiency Testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories, http://dx.doi.org/10.1101/2020.09.18.304519

Bull R; Adikari T; Ferguson J; Hammond J; Stevanovski I; Beukers A; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden J-S; Rawlinson W; van Hal S; Deveson I, 2020, Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis, http://dx.doi.org/10.1101/2020.08.04.236893

Roth-Schulze A; Penno M; Ngui K; Oakey H; Thomson R; Vuillermin P; Craig M; Rawlinson W; Davis E; Harris M; Soldatos G; Colman P; Wentworth J; Haynes A; Morahan G; Bediaga N; Smyth G; Papenfuss A; Couper J; Harrison L, 2020, Changes in the composition and function of the gut microbiome accompany type 1 diabetes in pregnancy, http://dx.doi.org/10.21203/rs.3.rs-18520/v1

Madala BS; Reis A; Deveson I; Rawlinson W; Mercer T, 2020, Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests, http://dx.doi.org/10.1101/2020.06.09.143412

Rouet R; Mazigi O; Walker G; Langley D; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry J; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull R; Turville S; Stewart A; Goodnow C; Rawlinson W; Christ D, 2020, Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies, http://dx.doi.org/10.1101/2020.12.14.422791

Kim KW; Deveson I; Pang CN; Yeang M; Naing Z; Adikari T; Hammond J; Stevanovski I; Beukers A; Verich A; Yin S; McFarlane D; Wilkins M; Stelzer-Braid S; Bull R; Craig M; Hal SV; Rawlinson W, 2020, Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing, http://dx.doi.org/10.21203/rs.3.rs-105996/v1

Walker G; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs S; Agapiou D; Bull R; Stelzer-Braid S; Daly J; Gosbell I; Hoad V; Irving D; Pink J; Turville S; Kelleher A; Rawlinson W, 2020, SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays, http://dx.doi.org/10.1101/2020.12.07.20245696

Walker G; Clifford V; Bansal N; Stella AO; Turville S; Stelzer-Braid S; Klein L; Rawlinson W, 2020, SARS-CoV-2 in human milk is inactivated by Holder pasteurization but not cold storage, http://dx.doi.org/10.1101/2020.06.18.20134395

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee F; Cunningham P; Walker G; Brown D; Rawlinson W; Isaacs S; Mathivanan V; Hoffman M; Pöhlmann S; Dwyer D; Rockett R; Sintchenko V; Hoad V; Irving D; Dore G; Gosbell I; Kelleher A; Matthews G; Brilot F; Turville S, 2020, SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants, http://dx.doi.org/10.1101/2020.12.19.20248567

Isaacs SR; Roy A; Dance B; Ward EJ; Foskett DB; Maxwell AJ; Rawlinson W; Kim KW; Craig ME, Enterovirus Infection and Risk of Islet Autoimmunity and Type 1 Diabetes: Systematic Review and Meta-Analysis of Molecular Studies, http://dx.doi.org/10.2139/ssrn.4308770

Back to profile page